HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Monica L. McDonald Victor F. Trastek Mark S. Allen Claude Deschamps Peter C. Pairolero Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McDonald, M. L. Articles by Pairolero, P. C. Search for Related Content PubMed PubMed Citation Articles by McDonald, M. L. Articles by Pairolero, P. C.

J Thorac Cardiovasc Surg 1996;111:1135-1140
© 1996 Mosby, Inc.

GENERAL THORACIC SURGERY

BARRETT'S ESOPHAGUS: DOES AN ANTIREFLUX PROCEDURE REDUCE THE NEED FOR ENDOSCOPIC SURVEILLANCE?

From the Section of General Thoracic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minn.

Received for publication June 21, 1995 Revisions requested Oct. 5, 1995; revisions received Jan. 6, 1996 Accepted for publication Jan. 15, 1996. Address for reprints: Victor F. Trastek, MD, 200 First St., S.W., Rochester, MN 55905.

Abstract

Barrett's esophagus, a premalignant condition associated with chronic gastroesophageal reflux, carries an approximate 40-fold increase in the incidence of adenocarcinoma. Between 1975 and 1994, 113 patients with Barrett's esophagus underwent antireflux procedures at the Mayo Clinic. The antireflux procedure was performed more than 3 months after the diagnosis of Barrett's disease in 39 patients (34.5%) and during the initial preoperative evaluation in 74 (65.5%). Uncut Collis-Nissen fundoplication was performed in 69 patients (61.1%), Nissen fundoplication was performed in 16 (14.2%), cut Collis-Nissen fundoplication was performed in 12 (10.6%), Belsey repair was performed in nine (8.0%), Collis-Belsey repair was performed in six (5.3%), and Nissen fundoplication with an anterior gastropexy was performed in one (0.9%). There was one operative death (0.9% mortality). Morbidity occurred in 41 patients (36.3%), including cardiac arrhythmia in eight (7.0%), pneumonia in six (5.3%), empyema in five (4.4%), hemorrhage in four (3.6%), myocardial infarction in two (1.8%), and wound dehiscence, wound infection, perforated duodenal ulcer, and postoperative leak in one each (0.9%). Median follow-up for the 112 survivors of operation was 6.5 years (range 4 months to 18.2 years). Excellent or good alleviation of symptoms was obtained in 92 patients (82.2%). Ninety-nine patients (88.4%) are currently alive and 13 (11.6%) have died. Three patients (2.7%) subsequently had adenocarcinoma of the esophagus after the antireflux procedure at 13, 25, and 39 months; two of these died of cancer. The incidence of esophageal carcinoma in this select group of patients was one in 273.8 patient-years of follow-up. We conclude that although antireflux procedures in patients with Barrett's esophagus result in long-term control of reflux symptoms, the possibility of esophageal cancer still exists. Endoscopic surveillance should therefore be recommended. (J THORAC CARDIOVASC SURG 1996;111:1135-40)

This article has been cited by other articles:

				P Sharma, S Wani, A P Weston, A Bansal, M Hall, S Mathur, A Prasad, and R E Sampliner A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut, September 1, 2006; 55(9): 1233 - 1239. [Abstract] [Full Text] [PDF]

				P. Lao-Sirieix, A. Roy, C. Worrall, S. L. Vowler, S. Gardiner, and R. C. Fitzgerald Effect of Acid suppression on molecular predictors for esophageal cancer. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 288 - 293. [Abstract] [Full Text] [PDF]

				M Solaymani-Dodaran, R F A Logan, J West, T Card, and C Coupland Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut, August 1, 2004; 53(8): 1070 - 1074. [Abstract] [Full Text] [PDF]

				A. E. Abbas, C. Deschamps, S. D. Cassivi, M. S. Allen, F. C. Nichols III, D. L. Miller, and P. C. Pairolero Barrett's esophagus: the role of laparoscopic fundoplication Ann. Thorac. Surg., February 1, 2004; 77(2): 393 - 396. [Abstract] [Full Text] [PDF]

				N. Shaheen and D. F. Ransohoff Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review JAMA, April 17, 2002; 287(15): 1972 - 1981. [Abstract] [Full Text] [PDF]

				J. Eksteen, A Latchford, S. Thomas, and J. Jankowski Commentary: Regional variations in oesophageal and gastric cardia cancers--implications and practice Int. J. Epidemiol., December 1, 2001; 30(6): 1425 - 1427. [Full Text] [PDF]

				L.-Q. Chen, D. Nastos, C.-Y. Hu, T. S. Chughtai, R. Taillefer, P. Ferraro, and A. C. Duranceau Results of the Collis-Nissen gastroplasty in patients with Barrett’s esophagus Ann. Thorac. Surg., September 1, 1999; 68(3): 1014 - 1020. [Abstract] [Full Text] [PDF]

				T. Lerut Esophageal surgery at the end of the millennium J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 1 - 20. [Full Text]

				P. F. Crookes and T. R. DeMeester The Diagnosis and Treatment of Gastroesophageal Reflux Disease in a Managed Care Environment: A Surgeon's Response Arch Surg, October 1, 1996; 131(10): 1021 - 1023. [Abstract] [PDF]